GILD

120.40

2.28% -2.81

시간 외 거래: 120.49 0.09 +0.07%

길리어드 사이언스 (GILD)

개요 뉴스 가격 이력 옵션 체인 Financials GILD 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$123.21

열려 있는:

$122.86

하루 거래량:

6.83M

Relative Volume:

0.95

시가총액:

$149.38B

수익:

$29.05B

순이익/손실:

$8.11B

주가수익비율:

18.65

EPS:

6.4563

순현금흐름:

$9.16B

1주 성능:

-0.68%

1개월 성능:

-2.43%

6개월 성능:

+7.45%

1년 성능:

+30.33%

1일 변동 폭

$119.53

$123.62

1주일 범위

$118.78

$123.74

52주 변동 폭

$88.57

$128.70

길리어드 사이언스 Stock (GILD) Company Profile

명칭

Gilead Sciences Inc

부문

Healthcare (1123)

산업

Drug Manufacturers - General (19)

전화

(650) 574-3000

주소

333 LAKESIDE DR, FOSTER CITY, CA

직원

17,600

트위터

@GileadSciences

다음 수익 날짜

2025-02-11

최신 SEC 제출 서류

GILD's Discussions on Twitter

GILD을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
GILD Gilead Sciences Inc	120.40	152.86B	29.05B	8.11B	9.16B	6.4563
LLY Lilly Eli Co	1,027.51	903.41B	59.42B	18.41B	6.44B	20.22
JNJ Johnson Johnson	211.58	505.98B	92.15B	25.12B	20.46B	10.36
ABBV Abbvie Inc	223.32	395.86B	59.64B	2.36B	19.68B	1.3253
NVS Novartis Ag Adr	132.57	253.97B	54.45B	14.42B	17.15B	7.333
MRK Merck Co Inc	100.30	245.75B	63.90B	19.05B	13.05B	7.5596

길리어드 사이언스 Stock (GILD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-11-24	재개	Truist	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-08-19	업그레이드	Daiwa Securities	Neutral → Outperform
2025-08-08	업그레이드	Truist	Hold → Buy
2025-07-25	업그레이드	Needham	Hold → Buy
2025-04-22	재개	Cantor Fitzgerald	Overweight
2025-03-04	재확인	Oppenheimer	Outperform
2025-02-18	업그레이드	Deutsche Bank	Hold → Buy
2025-02-13	업그레이드	DZ Bank	Hold → Buy
2025-01-10	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-11-14	개시	Citigroup	Buy
2024-11-08	다운그레이드	Maxim Group	Buy → Hold
2024-10-21	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-17	개시	Bernstein	Outperform
2024-10-07	업그레이드	Wells Fargo	Equal Weight → Overweight
2024-07-08	업그레이드	Raymond James	Mkt Perform → Outperform
2024-05-01	재확인	Maxim Group	Buy
2024-04-24	업그레이드	HSBC Securities	Reduce → Hold
2024-02-22	다운그레이드	Truist	Buy → Hold
2023-11-09	개시	Deutsche Bank	Hold
2023-09-08	업그레이드	BofA Securities	Neutral → Buy
2023-09-06	개시	HSBC Securities	Reduce
2023-07-24	재확인	Barclays	Equal Weight
2023-05-16	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-28	재개	Piper Sandler	Overweight
2023-01-03	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-12-13	재개	BofA Securities	Neutral
2022-12-09	다운그레이드	DZ Bank	Buy → Hold
2022-10-31	업그레이드	Barclays	Underweight → Equal Weight
2022-10-28	재확인	BMO Capital Markets	Market Perform
2022-10-28	재확인	Cowen	Outperform
2022-10-28	재확인	JP Morgan	Overweight
2022-10-28	재확인	Jefferies	Buy
2022-10-28	업그레이드	Piper Sandler	Neutral → Overweight
2022-10-28	재확인	RBC Capital Mkts	Outperform
2022-10-28	업그레이드	Truist	Hold → Buy
2022-10-28	재확인	Wells Fargo	Equal Weight
2022-10-04	업그레이드	JP Morgan	Neutral → Overweight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-05-23	개시	SVB Leerink	Mkt Perform
2022-02-28	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2022-02-02	재확인	BMO Capital Markets	Outperform
2022-02-02	재확인	BofA Securities	Neutral
2022-02-02	재확인	RBC Capital Mkts	Outperform
2022-02-02	재확인	Truist	Hold
2022-02-02	재확인	Wells Fargo	Equal Weight
2022-01-28	업그레이드	Argus	Hold → Buy
2022-01-06	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-12-09	재개	Wells Fargo	Equal Weight
2021-12-06	개시	Goldman	Neutral
2021-11-19	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-11-19	재개	Piper Sandler	Neutral
2021-10-20	재개	Cowen	Outperform
2021-07-30	재확인	BMO Capital Markets	Market Perform
2021-07-30	재확인	RBC Capital Mkts	Outperform
2021-04-01	업그레이드	Bernstein	Mkt Perform → Outperform
2021-03-30	업그레이드	Redburn	Neutral → Buy
2021-01-19	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-01-04	업그레이드	Guggenheim	Neutral → Buy
2020-11-03	재개	Morgan Stanley	Equal-Weight
2020-10-28	개시	UBS	Neutral
2020-09-30	재개	Jefferies	Buy
2020-09-15	업그레이드	Maxim Group	Hold → Buy
2020-07-31	재확인	Credit Suisse	Neutral
2020-07-31	재확인	Morgan Stanley	Equal-Weight
2020-07-31	재확인	Piper Sandler	Overweight
2020-07-31	재확인	RBC Capital Mkts	Outperform
2020-07-31	재확인	SunTrust	Hold
2020-07-31	재확인	Wells Fargo	Equal Weight
2020-07-20	업그레이드	Credit Suisse	Underperform → Neutral
2020-06-03	업그레이드	SVB Leerink	Mkt Perform → Outperform
2020-05-26	업그레이드	SunTrust	Sell → Hold
2020-05-01	다운그레이드	JP Morgan	Overweight → Neutral
2020-05-01	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-05-01	다운그레이드	SunTrust	Hold → Sell
2020-04-27	다운그레이드	UBS	Buy → Neutral
2020-04-20	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-04-20	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-04-17	다운그레이드	CFRA	Hold → Sell

모두보기

길리어드 사이언스 주식(GILD)의 최신 뉴스

01:14 AM

‘Au Revoir TIGIT’: Gilead, Arcus Cut Gastro Cancer Drug After Late-Stage Failure - BioSpace

01:14 AM

12:57 PM

GILEAD SCIENCES (GILD): Morgan Stanley Raises Price Target, Main - GuruFocus

12:57 PM

12:00 PM

Arcus cancels work on Gilead-partnered cancer combo after trial setback - BioPharma Dive

12:00 PM

10:36 AM

Arcus scraps late-stage cancer trial after weak survival data - Reuters

10:36 AM

09:38 AM

GILD: Gilead and Arcus End STAR-221 Study Due to Lack of Efficac - GuruFocus

09:38 AM

09:28 AM

Arcus, Gilead to Discontinue Phase 3 Trial of Potential Cancer Treatment -- Update - marketscreener.com

09:28 AM

09:21 AM

Morgan Stanley Adjusts PT on Gilead Sciences to $151 From $147, Maintains Overweight Rating - marketscreener.com

09:21 AM

09:13 AM

Gilead and Arcus halt late-stage study for anti-TIGIT cancer drug - Seeking Alpha

09:13 AM

08:36 AM

Gilead, Arcus scrap late-stage trial of cancer drug combo - Yahoo News Canada

08:36 AM

07:07 AM

Gilead Sciences, Inc. $GILD Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - MarketBeat

07:07 AM

05:58 AM

Sei Investments Co. Raises Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

05:58 AM

05:40 AM

NewEdge Advisors LLC Has $11.81 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

05:40 AM

03:18 AM

Alliancebernstein L.P. Sells 809,531 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

03:18 AM

Dec 11, 2025

Ex-Dividend Reminder: Gilead Sciences, Merck and Horace Mann Educators - Nasdaq

Dec 11, 2025

January 2026 Options Now Available For Gilead Sciences (GILD) - Nasdaq

Dec 11, 2025

The Manufacturers Life Insurance Company Sells 95,568 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Dec 11, 2025

Who Owns Gilead Sciences? Top Shareholders and Recent Insider Trades - TIKR.com

Dec 11, 2025

CIBC Asset Management Inc Sells 28,874 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Dec 11, 2025

Dec 10, 2025

Wells Fargo Maintains Gilead Sciences (GILD) Overweight Recommendation - Nasdaq

Dec 10, 2025

GILD: Wells Fargo Raises Price Target for Gilead Sciences | GILD Stock News - GuruFocus

Dec 10, 2025

Cantor Fitzgerald Maintains a Buy Rating on Gilead Sciences (GILD) - Insider Monkey

Dec 10, 2025

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $133.00 at HSBC - MarketBeat

Dec 10, 2025

Wells Fargo & Company Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - MarketBeat

Dec 10, 2025

Why You Might Be Interested In Gilead Sciences, Inc. (NASDAQ:GILD) For Its Upcoming Dividend - simplywall.st

Dec 10, 2025

Wells Fargo Adjusts Price Target on Gilead Sciences to $150 From $145, Maintains Overweight Rating - marketscreener.com

Dec 10, 2025

HSBC Adjusts Price Target on Gilead Sciences to $133 From $110, Maintains Hold Rating - marketscreener.com

Dec 10, 2025

30,000 Shares in Gilead Sciences, Inc. $GILD Bought by Diadema Partners LP - MarketBeat

Dec 10, 2025

Dymon Asia Capital Singapore PTE. LTD. Purchases Shares of 18,000 Gilead Sciences, Inc. $GILD - MarketBeat

Dec 10, 2025

Ariel Investments LLC Has $40.90 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Dec 10, 2025

Dec 09, 2025

Lombard Odier Asset Management Switzerland SA Raises Position in Gilead Sciences, Inc. $GILD - MarketBeat

Dec 09, 2025

Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer - Yahoo Finance

Dec 09, 2025

ASH25: CAR-T Leaders Gilead, J&J Show in Multiple Myeloma; Fulcrum Rises on Sickle Cell Data - BioSpace

Dec 08, 2025

WINTON GROUP Ltd Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat

Dec 08, 2025

ASH: Gilead preps filing for anito-cel on iMMagine-1 data - Pharmaphorum

Dec 08, 2025

What Does the Market Think About Gilead Sciences Inc? - Benzinga

Dec 08, 2025

Gilead Sciences, Inc. $GILD Shares Bought by Natixis - MarketBeat

Dec 08, 2025

35,296 Shares in Gilead Sciences, Inc. $GILD Bought by SVB Wealth LLC - MarketBeat

Dec 08, 2025

Gilead moves ahead on Chess Hatch project - San Mateo Daily Journal

Dec 08, 2025

L2 Asset Management LLC Buys 28,592 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Dec 08, 2025

Dec 07, 2025

Gilead Sciences (GILD) Stock: 7 Things to Know Before the Market Opens on December 8, 2025 - ts2.tech

Dec 07, 2025

GILD's Yescarta Shows Promising Results for Lymphoma Patients - GuruFocus

Dec 07, 2025

GILD's Kite Unveils Promising CAR T-Cell Therapy Results at ASH Meeting - GuruFocus

Dec 07, 2025

ASH: Gilead’s Kite Plots 2026 Launch For Anito-Cel For Multiple Myeloma - Citeline News & Insights

Dec 07, 2025

ASH: Anito-cel strengthens best-in-class potential as Gilead's Kite preps for launch - Fierce Biotech

Dec 07, 2025

New data from Gilead, Arcellx multiple myeloma CAR-T suggest benefit over rival treatment - statnews.com

Dec 07, 2025

Federated Hermes Inc. Sells 1,885,664 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Dec 07, 2025

Gilead Sciences, Inc. $GILD Position Decreased by Brown Advisory Inc. - MarketBeat

Dec 07, 2025